Orai1/Stim1 channel as a downstream mechanism also plays a significant role in ATP-induced Ca 21 signaling. ATP concentration-dependently stimulates hDP-MSC migration. Pharmacological and genetic interventions of the expression or function of the P2X7, P2Y 1 and P2Y 11 receptors, and Orai1/Stim1 channel support critical involvement of these Ca 21 signaling mechanisms in ATP-induced stimulation of hDP-MSC migration. Taken together, this study provide evidence to show that purinergic P2X7, P2Y 1 , and P2Y 11 receptors and store-operated Orai1/Stim1 channel represent important molecular mechanisms responsible for ATP-induced Ca 21 signaling in hDPMSCs and activation of these mechanisms stimulates hDP-MSC migration. Such information is useful in building a mechanistic understanding of MSC homing in tissue homeostasis and developing more efficient MSC-based therapeutic applications. STEM CELLS 2016;34:2102-2114 
INTRODUCTION
Calcium ion (Ca 21 ) is a ubiquitous intracellular messenger that has a crucial role in determining a plethora of cellular functions such as proliferation, migration, differentiation, and communication, and mammalian cells express numerous intrinsic mechanisms responding to various extrinsic signals with specific increases in the cytosolic Ca 21 level ([Ca 21 ] c ) and forming diverse cellular Ca 21 signatures with distinct spatial and temporal dynamics [1] . ATP has been recognized as one of such extrinsic signals to raise the [Ca 21 ] c via activating multiple plasma membrane P2X and P2Y receptors [2] [3] [4] [5] [6] . ATP binding to the P2X receptors opens Ca 21 -permeable channels mediating extracellular Ca 21 influx. ATP can also elevate the [Ca 21 ] c via G a,q/11 -protein-coupled P2Y receptors, and more specifically, activation of the P2Y 1 , P2Y 2 , and P2Y 11 receptors in human cells stimulates phospholipase C-b (PLC-b) to generate inositol-1,4,5-triphosphate (IP 3 ), which in turn activates the IP 3 receptor and induces Ca 21 release from the endoplasmic reticulum (ER). Reduction in the ER Ca 21 level can further induce store-operated Ca 21 entry through the Ca 21 release-activated Ca 21 (CRAC) a channels [7, 8] . Mesenchymal stem cells (MSCs) exhibit an ability to differentiate into osteoblasts, adipocytes, and chondrocytes [9] [10] [11] . These multipotent stem cells are readily isolated from various tissues, including bone marrow (BM-MSCs), adipose tissues (AT-MSCs), and dental pulp (DP-MSCs) and have been extensively explored as promising cell sources for therapeutic applications such as tissue regeneration and cellbased therapies in addition to being used in understanding tissue homeostasis [12] [13] [14] [15] [16] . Accumulating evidence shows that MSCs release ATP constitutively or in response to mechanical stimulation [17] [18] [19] [20] . Previous studies consistently demonstrated that ATP induced robust Ca 21 responses but reported expression of a bewildering variety of P2X and P2Y receptors in MSCs from different tissues and species [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] and, as a result, the cognate intrinsic mechanisms remains contentious. There is also evidence for occurrence of storeoperated Ca 21 entry in BM-MSCs [17] , but the molecular identity of the Ca 21 channels is still elusive. Several recent studies show that ATP significantly regulates MSC differentiation, although there are striking disparities in the findings and the proposed underlying mechanisms [20, 23, 24, 27] . MSCs are highly promising in cell-based therapies for challenging clinical conditions including cardiac infarction and neurodegenerative diseases and, once transplanted into the damaged or diseased tissues or organs, MSCs are anticipated to migrate into the recipient's tissue, and the poor homing capability is a critical factor limiting the effectiveness of in vitro expanded MSC cultures in clinical applications. How MSC migration is regulated is largely unknown. Therefore, this study examined the intrinsic mechanisms for ATP-induced Ca 21 signaling and their roles in the regulation of cell migration in human DP-MSCs (hDP-MSCs). Our results provide strong evidence to support the purinergic P2X7, P2Y 1 , and P2Y 11 receptors and identify the store-operated Orai1/ Stim1 channel as important molecular mechanisms underlying ATP-induced Ca 21 signaling and further show that activation of these mechanisms stimulates cell migration in hDP-MSCs.
MATERIALS AND METHODS

Chemicals and Culture Media
All general chemicals, including pyridoxal-phosphate-6-azophenyl-2 0 ,4 0 -disulfonic acid (PPADS), 2-aminoethoxydiphenyl borate (2-APB), and thapsigargin (TG), were purchased from Sigma-Aldrich (U.K., http://www.sigmaaldrich.com). AZ1164373, 5-(3-bromophenyl)21,3-dihydro-2H-benzofuro-[3,2-e]-1,4-diazepin-2-one (5-BDBD), and CGS15943 from Tocris Bioscience (U.K.). Phosphate-buffered saline (PBS), Dulbecco's modified Eagle's medium (DMEM), OPTI-MEM, fetal bovine serum (FBS), penicillin-streptomycin, trypsin-EDTA, pluronic acid F-127, and SYBR Green I were from Invitrogen (Carlsbad, CA, http://www.invitrogen.com), and collagenase P from Worthington Biochem (Lakewood, NJ, http://www.worthingtonbiochem.com/).
Cell Isolation and Characterization
All the experiments described below were carried out at room temperature, unless indicated otherwise. MSCs used for the vast majority of experiments were isolated from the molar teeth of three female donors (D1-D3: 9, 21, and 32 years old, respectively) and MSCs in a small number of experiments from 20 years old male donor, provided by the Leeds Dental Institute Dental Clinic. The procedures were approved by the Dental Research Ethics Committee of University of Leeds (280211/LJ/60). In brief, the pulp tissues were removed from the pulp chamber, minced into small pieces in 2 ml PBS containing 5 mg/ml collagenase P, and incubated in a humidified tissue culture incubator at 378C and 5% CO 2 for 45-60 minutes, with gentle pipetting every 15 minutes until the tissues were totally dispersed. After addition of 7 ml DMEM with 10% FBS, cells were collected by centrifugation (168g), re-suspended in 5 ml DMEM supplemented with 20% FBS, 2 mM L-glutamine, 100 units/ml penicillin, and 100 mg/ml streptomycin, and filtered using a 70-mm cell strainer. Cells were seeded in a T25 (25-cm 2 ) tissue culture plastic flask and incubated in a humidified tissue incubator at 378C and 5% CO 2 with the media changed every 3-4 days until reaching approximately 80% confluence. Cells were passaged using standard culture protocols and seeded in T25 or T75 (75-cm 2 ) flasks at a density of 1 3 10 4 cells per cm 2 . Cells were used up to five passages.
Expression of the MSC positive and negative cell surface protein markers was examined by flow cytometry using a FACSCalibur (BD Biosciences, San Diego, http://www.bdbiosciences.com). Cells were suspended in flow cytometry staining buffer (PBS containing 0.5% bovine serum albumin (BSA) and 2 mM EDTA) at 1 3 10 7 cells per ml before treated with Fc receptor blocking solutions (TruStain FcXTM, Biolegend) for 10 minutes, and 1 3 10 6 cells were incubated at 48C for 30 minutes with the following mouse anti-human antibodies: CD105-fluorescein isothiocyanate (FITC), CD90-FITC, CD73-phycoerythrin (PE), CD45-FITC, CD34-FITC, CD14-FITC, control-FITC, control-PE (Biolegend), and mouse anti-STRO-1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, http://www.scbt. com). Cells labeled with the anti-STRO-1 antibody were further incubated with FITC-conjugated goat anti-mouse IgG antibody (Invitrogen) at 48C for 30 minutes. After washing, cells were collected by centrifugation (168g) and resuspended in 400 ll flow cytometry staining buffer. Ten thousand events were recorded for each sample, and the data were analyzed with Cell Quest software (BD Biosciences).
For osteogenic differentiation, cells were seeded into 24-well plates at 4 3 10 4 cells per well and cultured in basal medium (BM) for 48 hours and then in BM or osteogenic medium (OM: 100 nM dexamethasone and 50 mM ascorbate-2-phosphate in BM) for 2 weeks, with the media replaced every 3 days. The expression of alkaline phosphatase was examined under a light microscope after cells were fixed in ethanol at 48C for 10 minutes and stained with 4% a-naphthol in water containing 24 mg/ml Fast violet B salt for 1 hour. For adipogenic differentiation, cells were seeded onto type I collagen-coated coverslips (BD Biosciences) placed in 24-well plates at 4 3 10 4 cells per well and cultured in BM for 48 hours before they were cultured in BM or adipogenic medium (AM: 0.5 mM isobutylmethylxanthine, 10 mM dexamethasone, 10 mg/ml insulin (Invitrogen), and 200 mM indomethacin in BM) for 3 weeks, with the media replaced every 3 days. Cells were fixed with 4% paraformaldehyde for 30 for 48 hours by gentle shaking and then in BM or chondrogenic medium (0.1 mM dexamethasone, 10 ng/ml Transforming growth factor (TGF)-b3, 50 mg/ml ascorbic acid 2-phosphate, 1.0 mg/ml recombinant human insulin, 0.55 mg/ml human transferrin, and 0.5 lg/ml sodium selenite in BM) for 3 weeks with the media changed every 3 days. Cell pellets were paraffin embedded, sectioned, and stained with Alcian blue and Sirius red [29] .
Reverse Transcriptase Polymerase Chain Reaction
Total RNA was extracted from one T75 flask of cells for each condition using TRI reagents and treated with RQ1 RNase-free DNase enzyme (Ambion, Austin, TX, http://www.ambion.com). The Ribogreen assay was carried out to determine the RNA concentrations. RNA was reverse-transcribed into cDNA using High Capacity RNA-to-cDNA Master Mix (Applied Biosystems, Foster City, CA, http://www.appliedbiosystems.com) using a Mastercycler Gradient PCR machine (Eppendorf) at 258C for 5 minutes, 428C for 30 minutes, and 858C for 5 minutes. The cDNA samples were amplified using PCR and primers specific to the target genes in 5 ll reaction volume containing 0.5 ll cDNA sample, 0.6 ll 4 mM MgCl 2 , 0.5 ll SYBR Green (Applied Biosystems), 0.25 ll 0.5 lM forward primer and 0.25 ll 0.5 lM reverse primer. The primer sequences were described in our previous studies [30, 31] [33] . The PCR products were analyzed by electrophoresis on 2% agarose gels, alongside with 100 bp DNA standards, and gel images were captured with a Biorad Gel Doc System.
Immunocytochemistry
Cells were seeded on coverslips with 15,000-20,000 per coverslip, placed in 24-well microplates, and incubated in a humidified tissue incubator at 378C and 5% CO 2 for 24 hours prior to immunostaining. Cells were fixed with 4% paraformaldehyde for 30 minutes. After wishing with PBS three times, cells were incubated in blocking solution (PBS containing 0.2% (1-3) . While P2X4, P2X6, P2X7, P2Y 1 , and P2Y 11 were consistently detected, there was no expression of P2X1, P2X2, P2X3, and P2X5, and P2Y 2 expression was extremely low or undetectable. The two arrows on the left denote 600 bp and 100 bp DNA markers, and the arrow head on the right points to the anticipated PCR product. Plasmids (P) containing P2X1, P2X2, P2X3, or P2X5 cDNA were used as DNA templates in PCR as positive control for primers. Triton X-100 and 5% goat serum or BSA) for 2 hours. Primary rabbit antibodies were diluted into the blocking solution at 1:50-100 for anti-P2X7, and 1:100 for anti-P2Y 1 and anti-P2Y 11 (all from Alomone Labs), and cells were incubated further at 48C for 24 hours. After washing with PBS containing 0.5% Tween-20 three times, cells were incubated in the blocking solution containing FITC-conjugated goat anti-rabbit IgG antibody at 1:1,000 (Sigma) at room temperature for 1.5 hours. After washing with PBS and rinsing with water, the coverslips were mounted on glass slides with DAPI-containing anti-fade mounting agent (Molecular Probes, Eugene, OR, http://probes.invitrogen.com) and kept at 48C overnight before images were captured using a LSM700 confocal microscope and ZEN software (Zeiss).
Measurement of the [Ca
21
] c
The [Ca 21 ] c was monitored using single cell imaging and FlexStation, as described in our previous studies [34] [35] [36] . Cells were seeded on type I collagen-coated coverslips placed in 24-well plates at a 2 3 10 3 cells per cm 2 for single cell imaging or in 96-well assay plates at 4 3 10 4 cells per well for FlexStation. Cells were loaded with 4 lM Fura-2/AM (Molecular Probes) and 0.4% pluronic acid F-127 in standard Ca 21 containing bath solution (SBS: 147 mM NaCl, 2 mM KCl, 1.5 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, and 13 mM glucose 13, pH 7.3) at 378C for 1 hour, and after washing, incubated in SBS at 378C for 30 minutes. Cells were washed again and replaced with fresh SBS or Ca 21 -free solution (147 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 1.147 mM EDTA, 10 mM HEPES, and 13 mM glucose, pH 7.3). For single cell imaging, a coverslip with cells was placed in a recording chamber under an Axiovert S100 TV fluorescent microscope (Zeiss). Cells were perfused with SBS or Ca 21 -free solutions. The fluorescence intensity from selected single cells was imaged every 10 seconds. Cells were perfused with indicated extracellular solutions for 60 seconds to establish the baseline before adding agonist. The fluorescence intensity from a small collection of cells was measured every 5-10 seconds using FlexStation II or III and Softmax Pro (Molecular Devices, Union City, CA, http:// www.moleculardevices.com). Agonists were added after 60 seconds to establish the baseline. The [Ca 21 ] c was monitored by the ratio of the fluorescence intensity at 510 nm excited alternatively by 340 nm and 380 nm (F 340 /F 380 ). Data analysis was carried out using OriginPro 8.0. The agonist concentration-response curves (Figs 
Cell Migration Assays
Cell migration was assessed using the wound healing and trans-well migration assays. For the wound healing assay, cells were seeded in 96-well plates at 4 3 10 5 cells per well and cultured for 48 hours to form confluent monolayers. The wound was introduced across the well by removing the cells using a 96-pin WoundMaker (Essen BioScience). Cell migration was monitored by measuring the average wound width narrowing every hour using Incucyte (Essen BioScience). Cell migration was also estimated by staining cells with SYBR Green, imaging two wound areas in each well using IncuCyte, counting the number of cells migrating into the wound area, corrected by the cell density in adjacent healthy area in the same well. The trans-well migration 
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assays were carried out in 24-well plates receiving polyethylene terephthalate membrane cell culture inserts containing trans-well pores of 8 lm in diameter (BD Biosciences). The upper compartment was seeded with 5 3 10 4 cells, and both the upper and lower compartments were filled with DMEM with 10% FBS. ATP was added into the lower compartment. After incubation at 378C and 5% CO 2 for 6 or 18 hours, cells attached to the side of the inserts facing the lower compartment were stained with 0.1% crystal violet prepared in 20% methanol and 80% distilled water for cell migration at 6 hours and Hoechst (5 ng/ml) for cell migration at 18 hours; cells in three to five different areas of the inserts were imaged using an IX51 microscope and Cell F imaging system (Olympus) or a fluorescent microscope EVOSV R Cell Imaging System (Zeiss). The stained cells with a size that was discernibly greater than the size of the pore were counted. For meaningful comparisons between separate experiments, relative cell migration was expressed by % of that in the absence of ATP.
Treatments with Agonists and Antagonists
In single cell imaging and FlexStation measurements of the [Ca 21 ] c , cells were exposed to ATP or other agonists during recordings. In some experiments, cells were pretreated with PPADS, 5-BDBD, 2-APB, AZ11645373, and TG during last 30 minutes incubation. In cell migration assays, antagonist was added in culture medium 30 minutes before addition of ATP.
Transfection with siRNA
Cells were seeded in 96-well plates for measurements of the [Ca 21 ] c and cell migration, and in six-well plates for measurements of the gene expression using reverse transcriptase polymerase chain reaction (RT-PCR) at the cell densities described above. After 24 hours incubation, cells were transfected with siRNAs directed against target gene or scrambled small interference RNA (siRNA) (Scr-siRNA), provided by Ambion. The specificity was verified by the vendor and our previous studies [31] . For each transfection, 4 ml 20 lM siRNA and 4 ml Lipofectamine2000 (Invitrogen) was separately diluted in 200 ml OPTI-MEM medium and incubated for 5 minutes before they were mixed and incubated for further 20 minutes and supplemented with 1.6 ml culture media. Cells in each well were covered with the transfection medium (100 ml for each well of 96-well plates and 1 ml for each well of 6-well plates) and cultured for 48-72 hours before use.
Data Presentation and Analysis
All data are presented as mean 6 SEM, where appropriately. Figures show representative data from cells from the first donor and also show the mean data from the first three donors. Statistical analysis was carried out using Student's t test to compare two groups or one-way ANOVA with Tukey post hoc test to compare more than two groups by Origin software, with p < .05 being indicative of significance.
RESULTS
P2X7, P2Y 1 , and P2Y 11 Receptors Participate in ATPInduced Ca 21 Signaling
Cells used in this study exhibited the characteristics proposed for MSCs [11] , namely, they were adherent to plastic surface, displayed fibroblast-like morphology, and underwent osteogenic, adipogenic and chondrogenic differentiation under defined inducing conditions (Supporting Information Fig. 1 ). These cells also showed expression of MSC positive markers, CD73, CD90, CD105, and Stro-1, and lack of hematopoietic and endothelial cell markers, CD14, CD34, and CD45 (Supporting Information Fig. 2) .
To characterize the expression of ATP-induced Ca 21 signaling mechanisms in hDP-MSCs, RT-PCR was firstly used to analyze the expression of ATP-sensitive purinergic P2 receptors, P2X1-7, P2Y 1 , P2Y 2 , and P2Y 11 . In cells from the three donors examined, the mRNA transcript was detected for P2X4, P2X6, and P2X7, but not for P2X1, P2X2, P2X3, and P2X5 (Fig. 1A) . Among the three ATP-sensitive P2Y receptors, the mRNA expression of P2Y 1 and P2Y 11 was readily detected, whereas the P2Y 2 expression was extremely low or undetectable (Fig.  1A) (Fig. 1D, 1E) . Construction of ATP concentrationCa 21 response relationship curve and fitting to Hill equation yielded an EC 50 of 22 mM and n H of 0.5 (Fig. 1F) . ATP-induced increases in the [Ca 21 ] c in extracellular Ca 21 -containing solutions were reduced by 10 lM PPADS, a generic P2 antagonist (Fig. 1G, 1H) , and almost completely abolished by 30 lM PPADS (Supporting Information Fig. 3a, 3c) . These results provide initial but clear evidence to confirm the expression of functional P2 receptors as the cognate Ca 21 signaling mechanisms to respond to extracellular ATP in MSCs.
Consistent with lack of the P2X1, P2X3, or P2X5 mRNA expression, 100 lM abmeATP induced no discernible Ca 21 response ( Fig. 2A) , indicating lack of functional P2X receptors containing any of these subunits, at which abmeATP is known as a potent agonist [6] . In contrast, 300 lM BzATP evoked a greater increase in the [Ca 21 ] c than 300 lM ATP ( Fig. 2A) , indicating that BzATP is more potent than ATP. Construction and fitting of BzATP concentration-Ca 21 response relationship curve yielded an EC 50 of 87 lM and n H of 1.4 (Fig. 2B) . ATPinduced increase in the [Ca 21 ] c was significantly reduced by 1 lM AZ11645373 (Fig. 2C) , a human P2X7 selective antagonist [37] . In contrast, ATP-induced Ca 21 response was completely insensitive to 10 lM 5-BDBD (Fig. 2D) , a P2X4 specific antagonist with submicromolar potency [38] , indicating lack of functional P2X4 receptor. Transfection of hDP-MSCs with P2X7-siRNA led to significant reduction in the P2X7 expression (Fig.  2E ) and the Ca 21 responses induced by both BzATP and ATP (Fig. 2F, 2G ), whereas transfection with scrambled siRNA (ScrsiRNA) resulted in no detectable inhibition ( Fig. 2H ; Supporting Information Fig. 4) . The greater potency of BzATP over ATP and the sensitivity of Ca 21 responses induced by ATP and BzATP to inhibition by AZ11645373 and P2X7-siRNA were consistently observed in cells from three donors examined (Fig.  2I, 2J ). These results provide compelling evidence to support the expression of functional P2X7 receptor.
ATP induced substantial increases in the [Ca 21 ] c in extracellular Ca 21 -free solutions (Fig. 1C, 1E ; Supporting Information Fig. 3c ). Such ATP-induced Ca 21 responses were almost completely abolished by 30 lM PPADS (Supporting Information  Fig. 3b, 3c) . These results indicate functional expression of ATP-sensitive PLC-IP 3 -coupled P2Y receptors. To further elaborate the P2Y receptors, internal Ca 21 release induced by P2Y subtype-preferring agonists was determined in extracellular Ca 21 -free solution. ADP, an agonist at P2Y 1 , and BzATP, an agonist at P2Y 1 and P2Y 11 , both applied at 100 lM, evoked substantial Ca 21 release, albeit with variable amplitudes (Fig.  2K, 2I) . Moreover, knockdown of the P2Y 1 expression (Fig.  2M ) attenuated the increases in the [Ca 21 ] c induced by ATP (Fig. 2N) and ADP (Fig. 2O) (Fig. 2Q) . These results, even though bearing some variations, were consistently observed in cells from the three donors examined (Fig. 2R) , and therefore strongly support participation of the P2Y 1 and P2Y 11 receptors in ATP-induced Ca 21 signaling. To provide further supporting evidence, immunofluorescence confocal microscopy was used to examine protein expression of the P2X7, P2Y 1 , and P2Y 11 receptors. There were strong immunoreactivities in cells labeled with the antibody recognizing the P2X7, P2Y 1 , or P2Y 11 receptor, respectively (Supporting Information Fig. 5 ). Taken together, the results described above provide consistent evidence to show entry as compared to those in non-transfected cells (Supporting Information Fig. 8 ). Transfection with specific siRNA for Orai1, Stim1, and Stim2, as shown in our previous study [31] , led to strong reduction in the expression of Orai1, Stim1, and Stim2 (Fig.  4B) . Transfection with any of these siRNAs caused no effect on the constitutive Ca 21 influx (in grey in Fig. 4C, 4D ). However, transfection with Orai1-siRNA, Stim1-siRNA but not Stim2-siRNA significantly attenuated TG-induced store-operated Ca 21 entry (Fig. 4C) . Cotransfection with Orai1-siRNA and Stim1-siRNA inhibited TGinduced store-operated Ca 21 entry but there was no additive or synergistic inhibition (Fig. 4D) . Consistently, knockdown of the expression of Orai1, Stim1 or both, but not Stim2, significantly reduced ATP-induced increases in the [Ca 21 ] c in extracellular Ca 21 -containing solution (Fig. 4E, 4F ). These results, consistently observed in cells from the three donors examined (Fig. 4G, 4H) , provide the first evidence to show that Orai1 and Stim1 form the CRAC channel and further support that store-operated Ca 21 entry has an important role in ATP-induced Ca 21 signaling in MSCs.
Extracellular ATP Stimulates hDP-MSC Migration
It was unclear whether ATP regulated MSC migration and thus the wound healing assay in combination with time-lapse imaging was used to determine the effect of ATP on hDP-MSC migration. Figure 5A , 5B illustrates a set of representative Detailed analysis of the wound healing area at 24, 48, and 72 hours indicates that the wound healing process remained not altered by 3 lM ATP but was accelerated by approximately 50% by 30 lM ATP (Fig. 5C, 5D ). Similar results were obtained by nucleus staining and counting of cells migrating into the wound area during 24 hours; the number of cells in the wound area in the presence of 3 lM ATP were similar to, but the number of cells in the wound are in the presence of 30 lM ATP significantly greater than, that under condition (Fig.  5E ). These results were consistently observed in cells from three donors examined (Fig. 5F, 5G ), demonstrating that ATP induces concentration-dependent stimulation of hDP-MSC migration. Trans-well chamber assay also showed that cell migration was noticeably increased after exposure to ATP for 18 hours (Supporting Information Fig. 9 ). It is recognized that during such relatively long exposure ATP is steadily metabolized to ADP and particularly further to adenosine, which can act on structurally and functionally distinctive adenosine receptors [41] . Increased cell migration could arise from activation of adenosine receptors. However, ATP-induced stimulation of hDP-MSC migration was not significantly inhibited by 1 lM CGS15943, a generic adenosine receptor inhibitor with submicromolar potency [42] , and by contrast completely abolished by 30 lM PPADS (Fig. 6A, 6B ). These results, observed in cells from all three donors (Fig. 6C) , show that ATP stimulates hDP-MSC migration predominantly via activation of the P2 receptors.
P2X7, P2Y 1 , and P2Y 11 Receptors, and Orai1/Stim1 Channel Play a Role in Mediating ATP Stimulation of hDP-MSC Migration Finally, the role of the above-described ATP-induced Ca 21 signaling mechanisms in ATP-induced stimulation of hDP-MSCs was investigated by determining the effects of pharmacological and genetic inhibition of their expression and/or function. ATP-induced stimulation of cell migration was attenuated by 1 lM AZ11645373 or 5 lM 2-APB ( Fig. 6A-6C ). ATP-induced stimulation of cell migration was also significantly reduced by siRNA knockdown of the expression of P2X7 or P2Y 11 receptor (Fig. 7A-7C ). Moreover, ATP-induced stimulation of hDP-MSC migration was strongly inhibited by siRNA knockdown of the expression of Stim1 or both Orai1 and Stim1 (Fig. 7A, 7D, 7E) . Knockdown of the P2Y 1 or Orai1 expression resulted in significant inhibition of ATP-induced stimulation of cell migration in hDP-MSCs, albeit the inhibition being less effective and more variable among different donors (Fig. 7B, 7C ). These results overall support that the P2X7, P2Y 1 and P2Y 11 receptors and the Orai1/Stim1 channel play a significant role in ATP-induced stimulation of hDP-MSC migration.
DISCUSSION
This study has made several important findings. First, the P2X7, P2Y 1 , and P2Y 11 receptors are identified as molecular mechanisms that contribute in mediating ATP-induced Ca 21 signaling in hDP-MSCs. Second, the Orai1/Stim1 CRAC channel is expressed and mediates store-operated Ca 21 entry in hDPMSCs and, as a downstream mechanism following activation of the P2Y receptors, participates in ATP-induced Ca 21 signaling. Third, ATP stimulates hDP-MSC migration, and finally, the above-described purinergic and store-operated Ca 21 signaling mechanisms play a significant role in mediating ATP-induced stimulation of hDP-MSC migration.
As introduced above, previous studies consistently showed that extracellular ATP induced pronounced increases in the [Ca 21 ] c in MSCs but reported expression of a striking variety of P2X and P2Y receptors, in part due to the fact that MSCs used in previous studies were from different tissue origins or less well-defined donors. This study examined hDP-MSCs from several donors and obtained consistent evidence to demonstrate that P2X7, P2Y 1 , and P2Y 11 are the purinergic P2 receptors responsible for ATP-induced Ca 21 signaling in hDP-MSCs ( Figs. 1 and 2 ), confirming expression of these P2 receptors in MSCs reported by some previous studies using BM-MSCs and AT-MSCs [19] [20] [21] [22] 28] . Nonetheless, this study observed noticeable variations in the results obtained in cells from different donors, for example, at both mRNA and functional expression levels (Figs. 1A, 4A ). Such variations may explain to some extent the variable efforts of treating cells with the same inhibitor or siRNA on ATP-induced Ca 21 responses (Fig. 2R ) and stimulation of cell migration (Figs. 6B, 6C , 7B-7D) that were noticed in this study, as well as the disparate results reported by previous studies. This study has provided the first evidence, as far as we are aware, to identify that Orai1 and Stim1 are expressed in hDP-MSCs and form a CRAC channel to mediate store-operated Ca 21 entry and, furthermore, Orai1/Stim1-mediated Ca 21 entry contributes to ATP-induced Ca 21 signaling as an important downstream mechanism following the P2Y receptor activation (Figs. (3 and 4) ).
The ability of MSC differentiation along specific lineages is clearly important for tissue regeneration and replacement. Several recent studies show that ATP regulates adipogenesis and osteogenesis of hBM-MSC and hAT-MSCs, albeit with discrepancies in the reported findings and the proposed underlying mechanisms [20, 23, 24, 27] . The poor migration/homing capacity of in vitro expanded MSC cultures is critical in limiting the effectiveness of MSC-based therapies. This study using the widely used cell migration assays showed that ATP at micromolar concentrations stimulates hDP-MSC migration (Fig. 6 ). Furthermore, this study using pharmacological and genetic interventions provides consistent evidence to suggest that the P2X7, P2Y 1 , and P2Y 11 receptors and the Orai1/Stim1 channel play a significant role in ATP-induced stimulation of hDP-MSC migration (Fig. 7) . This is the first report describing ATP-induced stimulation of MSC migration and shedding light on the underlying mechanisms. Evidently, further efforts are required to better understand how purinergic and store-operated Ca 21 signals regulate cell migration and whether in vitro priming with ATP increases the homing capacity of MSC in vivo. Emerging evidence shows that extracellular magnesium influences ATP-induced Ca 21 signaling and mineralized matrix deposition in BM-MSC [43] , and it is interesting to examine whether extracellular magnesium can affect ATPinduced regulation of MSC migration.
CONCLUSION
In conclusion, this study shows that purinergic P2X7, P2Y 1 , and P2Y 11 receptors and store-operated Orai1/Stim1 channel represent the intrinsic mechanisms for ATP-induced Ca 21 signaling in hDP-MSCs and activation of such signaling mechanisms stimulates cell migration. Such information is useful in optimizing MSC cultures to improve the efficiency of their therapeutic applications as well as in better understanding MSC-mediated tissue homeostasis.
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